Inhibitor development in previously untreated patients (PUPs) with hemophilia A and B: A prospective 23-year-follow-up

被引：0
|
作者：
Ettingshausen, CE
Zyschka, A
Oldenburg, J
Saguer, IM
Ehrenforth, S
Kreuz, W
Goethe, JW
机构：
[1] JW Goethe Univ Hosp, Dept Pediat, Frankfurt, Germany
[2] Univ Wurzburg, Inst Human Genet, D-8700 Wurzburg, Germany
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1300
引用
收藏
页码：410 / 410
页数：1
相关论文
共 50 条
  • [1] Inhibitor development in previously untreated patients with hemophilia A and B: A prospective 23-year follow-up
    Ettingshausen, CE
    Zyschka, A
    Oldenburg, J
    Saguer, IM
    Ehrenforth, S
    Kreuz, W
    30TH HEMOPHILIA SYMPOSIUM, 2001, : 110 - 113
  • [2] Inhibitor incidence in previously untreated patients (PUP) with hemophilia A and B - a 10-year-follow up of the prospective multicenter study.
    Kreuz, W
    Auerswald, GKH
    Budde, U
    Lenk, H
    BLOOD, 2004, 104 (11) : 81B - 81B
  • [3] INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE
    LUSHER, J
    ARKIN, S
    ABILDGAARD, C
    INWOOD, M
    HILGARTNER, M
    HURST, D
    PEDIATRIC RESEARCH, 1994, 35 (04) : A165 - A165
  • [4] Validation of the prediction score for inhibitor development in previously untreated patients (PUPs) with severe hemophilia A
    Hashemi, S.
    Fischer, K.
    Van den Berg, H.
    HAEMOPHILIA, 2012, 18 : 89 - 89
  • [5] Inhibitors in previously untreated patients (PUPS) with severe hemophilia A: a follow-up cohort study
    Mancuso, M. E.
    van den Berg, H. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 846 - 846
  • [6] Ten-year follow-up of inhibitor induction in previously untreated patients (PUPs) on recombinate.
    Aledort, LM
    White, GC
    Rivard, GE
    BLOOD, 2004, 104 (11) : 87B - 87B
  • [7] Low inhibitor incidence in previously untreated hemophilia A patients (PUPs) treated with Octanate®
    Klukowska, A.
    Laguna, P.
    Komrska, V.
    Jansen, M.
    HAEMOPHILIA, 2010, 16 : 37 - 37
  • [8] Inhibitor development in previously untreated patients with hemophilia A: A prospective long-term follow-up comparing plasma-derived and recombinant products
    Kreuz, W
    Ettingshausen, CE
    Zyschka, A
    Oldenburg, J
    Saguer, IM
    Ehrenforth, S
    Klingebiel, T
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (03): : 285 - 290
  • [9] INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATMENT PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE
    LUSHER, JM
    ARKIN, S
    ABILDGAARD, CF
    INWOOD, M
    ZIMMERMANN, R
    HILGARTNER, M
    HURST, D
    BLOOD, 1993, 82 (10) : A153 - A153
  • [10] Inhibitor incidence in previously untreated patients (PUPs) with severe hemophilia A receiving recombinant factor (rFVIII)
    Rothschild, C
    Laurian, Y
    Satre, EP
    BorelDerlon, A
    Chambost, H
    Moreau, P
    Goudemand, J
    Parquet, A
    Vicariot, M
    Beurrier, P
    Claeyssens, S
    Durin, A
    Faradji, A
    Fressinaud, E
    Gaillard, S
    Guerin, V
    Guerois, C
    Pernod, G
    Peynet, J
    Pouzol, P
    Schved, JF
    Gazengel, C
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2654 - P2654
12345